17-74769076-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004252.5(NHERF1):c.*420C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.503 in 197,548 control chromosomes in the GnomAD database, including 25,323 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.50 ( 19384 hom., cov: 33)
Exomes 𝑓: 0.51 ( 5939 hom. )
Consequence
NHERF1
NM_004252.5 3_prime_UTR
NM_004252.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.392
Publications
20 publications found
Genes affected
NHERF1 (HGNC:11075): (NHERF family PDZ scaffold protein 1) This gene encodes a sodium/hydrogen exchanger regulatory cofactor. The protein interacts with and regulates various proteins including the cystic fibrosis transmembrane conductance regulator and G-protein coupled receptors such as the beta2-adrenergic receptor and the parathyroid hormone 1 receptor. The protein also interacts with proteins that function as linkers between integral membrane and cytoskeletal proteins. The protein localizes to actin-rich structures including membrane ruffles, microvilli, and filopodia. Mutations in this gene result in hypophosphatemic nephrolithiasis/osteoporosis type 2, and loss of heterozygosity of this gene is implicated in breast cancer.[provided by RefSeq, Sep 2009]
NHERF1 Gene-Disease associations (from GenCC):
- hypophosphatemic nephrolithiasis/osteoporosis 2Inheritance: AD, Unknown Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
- dominant hypophosphatemia with nephrolithiasis or osteoporosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.522 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NHERF1 | NM_004252.5 | c.*420C>T | 3_prime_UTR_variant | Exon 6 of 6 | ENST00000262613.10 | NP_004243.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.501 AC: 76188AN: 152074Hom.: 19336 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
76188
AN:
152074
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.507 AC: 22990AN: 45356Hom.: 5939 Cov.: 0 AF XY: 0.505 AC XY: 11723AN XY: 23198 show subpopulations
GnomAD4 exome
AF:
AC:
22990
AN:
45356
Hom.:
Cov.:
0
AF XY:
AC XY:
11723
AN XY:
23198
show subpopulations
African (AFR)
AF:
AC:
438
AN:
938
American (AMR)
AF:
AC:
1743
AN:
3150
Ashkenazi Jewish (ASJ)
AF:
AC:
607
AN:
1258
East Asian (EAS)
AF:
AC:
499
AN:
1598
South Asian (SAS)
AF:
AC:
2494
AN:
5506
European-Finnish (FIN)
AF:
AC:
1337
AN:
2342
Middle Eastern (MID)
AF:
AC:
68
AN:
180
European-Non Finnish (NFE)
AF:
AC:
14517
AN:
27874
Other (OTH)
AF:
AC:
1287
AN:
2510
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
533
1067
1600
2134
2667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.501 AC: 76290AN: 152192Hom.: 19384 Cov.: 33 AF XY: 0.502 AC XY: 37329AN XY: 74400 show subpopulations
GnomAD4 genome
AF:
AC:
76290
AN:
152192
Hom.:
Cov.:
33
AF XY:
AC XY:
37329
AN XY:
74400
show subpopulations
African (AFR)
AF:
AC:
19827
AN:
41520
American (AMR)
AF:
AC:
7961
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
1723
AN:
3470
East Asian (EAS)
AF:
AC:
1584
AN:
5180
South Asian (SAS)
AF:
AC:
2088
AN:
4812
European-Finnish (FIN)
AF:
AC:
5869
AN:
10602
Middle Eastern (MID)
AF:
AC:
134
AN:
294
European-Non Finnish (NFE)
AF:
AC:
35786
AN:
67998
Other (OTH)
AF:
AC:
1030
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1986
3973
5959
7946
9932
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
686
1372
2058
2744
3430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1328
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.